These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26886298)

  • 1. Strain Differences Determine the Suitability of Animal Models for Noninvasive In Vivo Beta Cell Mass Determination with Radiolabeled Exendin.
    Willekens SM; Joosten L; Boerman OC; Balhuizen A; Eizirik DL; Gotthardt M; Brom M
    Mol Imaging Biol; 2016 Oct; 18(5):705-14. PubMed ID: 26886298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Specific Activity by Multichelation of Exendin-3 Leads To Improved Image Quality and In Vivo Beta Cell Imaging.
    Joosten L; Brom M; Peeters H; Heskamp S; Béhé M; Boerman O; Gotthardt M
    Mol Pharm; 2018 Feb; 15(2):486-494. PubMed ID: 29226686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo imaging of pancreatic beta cells using a radiolabeled GLP-1 receptor agonist.
    Connolly BM; Vanko A; McQuade P; Guenther I; Meng X; Rubins D; Waterhouse R; Hargreaves R; Sur C; Hostetler E
    Mol Imaging Biol; 2012 Feb; 14(1):79-87. PubMed ID: 21394533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species differences in pancreatic binding of DO3A-VS-Cys
    Eriksson O; Rosenström U; Selvaraju RK; Eriksson B; Velikyan I
    Acta Diabetol; 2017 Nov; 54(11):1039-1045. PubMed ID: 28891030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring the Pancreatic β Cell Mass in Vivo with Exendin SPECT during Hyperglycemia and Severe Insulitis.
    Joosten L; Brom M; Peeters H; Bos D; Himpe E; Bouwens L; Boerman O; Gotthardt M
    Mol Pharm; 2019 Sep; 16(9):4024-4030. PubMed ID: 31345042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Cu-64 and Ga-68 Radiolabeled Glucagon-Like Peptide-1 Receptor Agonists as PET Tracers for Pancreatic β cell Imaging.
    Bandara N; Zheleznyak A; Cherukuri K; Griffith DA; Limberakis C; Tess DA; Jianqing C; Waterhouse R; Lapi SE
    Mol Imaging Biol; 2016 Feb; 18(1):90-8. PubMed ID: 25987465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved Quantification of the Beta Cell Mass after Pancreas Visualization with
    van der Kroon I; Joosten L; Nock BA; Maina T; Boerman OC; Brom M; Gotthardt M
    Mol Pharm; 2016 Oct; 13(10):3478-3483. PubMed ID: 27537699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive quantification of the beta cell mass by SPECT with ¹¹¹In-labelled exendin.
    Brom M; Woliner-van der Weg W; Joosten L; Frielink C; Bouckenooghe T; Rijken P; Andralojc K; Göke BJ; de Jong M; Eizirik DL; Béhé M; Lahoutte T; Oyen WJ; Tack CJ; Janssen M; Boerman OC; Gotthardt M
    Diabetologia; 2014 May; 57(5):950-9. PubMed ID: 24488022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of an
    Kimura H; Fujita N; Kanbe K; Matsuda H; Watanabe H; Arimitsu K; Fujimoto H; Hamamatsu K; Yagi Y; Ono M; Inagaki N; Saji H
    Bioorg Med Chem; 2017 Oct; 25(20):5772-5778. PubMed ID: 28927802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (111)In-exendin uptake in the pancreas correlates with the β-cell mass and not with the α-cell mass.
    Brom M; Joosten L; Frielink C; Boerman O; Gotthardt M
    Diabetes; 2015 Apr; 64(4):1324-8. PubMed ID: 25409700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo imaging of the glucagonlike peptide 1 receptor in the pancreas with 68Ga-labeled DO3A-exendin-4.
    Selvaraju RK; Velikyan I; Johansson L; Wu Z; Todorov I; Shively J; Kandeel F; Korsgren O; Eriksson O
    J Nucl Med; 2013 Aug; 54(8):1458-63. PubMed ID: 23761918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of novel radioiodinated exendin-4 derivatives targeting GLP-1 receptor for detection of β-cell mass.
    Ogawa Y; Kimura H; Fujimoto H; Kawashima H; Toyoda K; Mukai E; Yagi Y; Ono M; Inagaki N; Saji H
    Bioorg Med Chem; 2021 Dec; 52():116496. PubMed ID: 34808404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive glucagon-like peptide-1 receptor imaging in pancreas with (18)F-Al labeled Cys(39)-exendin-4.
    Mi B; Xu Y; Pan D; Wang L; Yang R; Yu C; Wan W; Wu Y; Yang M
    Biochem Biophys Res Commun; 2016 Feb; 471(1):47-51. PubMed ID: 26850848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking of Glucagonlike Peptide-1 Receptors in the Exocrine Pancreas Improves Specificity for β-Cells in a Mouse Model of Type 1 Diabetes.
    Khera E; Zhang L; Roberts S; Nessler I; Sandoval D; Reiner T; Thurber GM
    J Nucl Med; 2019 Nov; 60(11):1635-1641. PubMed ID: 31076502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exendin-4 Derivatives with an Albumin-Binding Moiety Show Decreased Renal Retention and Improved GLP-1 Receptor Targeting.
    Kaeppeli SAM; Jodal A; Gotthardt M; Schibli R; Béhé M
    Mol Pharm; 2019 Sep; 16(9):3760-3769. PubMed ID: 31393738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Islet-selectivity of G-protein coupled receptor ligands evaluated for PET imaging of pancreatic β-cell mass.
    Cline GW; Zhao X; Jakowski AB; Soeller WC; Treadway JL
    Biochem Biophys Res Commun; 2011 Sep; 412(3):413-8. PubMed ID: 21820405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of
    Kimura H; Ogawa Y; Fujimoto H; Mukai E; Kawashima H; Arimitsu K; Toyoda K; Fujita N; Yagi Y; Hamamatsu K; Murakami T; Murakami A; Ono M; Nakamoto Y; Togashi K; Inagaki N; Saji H
    Bioorg Med Chem; 2018 Jan; 26(2):463-469. PubMed ID: 29273416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiolabelled GLP-1 analogues for in vivo targeting of insulinomas.
    Brom M; Joosten L; Oyen WJ; Gotthardt M; Boerman OC
    Contrast Media Mol Imaging; 2012; 7(2):160-6. PubMed ID: 22434628
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.